marketscan® commercial claims and encounters (ccae) and medicare supplemental databases (Truven Health)
90
Structured Review
Truven Health
marketscan® commercial claims and encounters (ccae) and medicare supplemental databases
Marketscan® Commercial Claims And Encounters (Ccae) And Medicare Supplemental Databases, supplied by Truven Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ccae+database/health+marketscan+database/pm39243246-93-81-81
Average 90 stars, based on 1 article reviews
Marketscan® Commercial Claims And Encounters (Ccae) And Medicare Supplemental Databases, supplied by Truven Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ccae+database/health+marketscan+database/pm39243246-93-81-81
Average 90 stars, based on 1 article reviews
marketscan® commercial claims and encounters (ccae) and medicare supplemental databases - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Cardiovascular Safety Profile of BRAF and MEK Inhibitors in Melanoma: FAERS Data Through a Retrospective Disproportionality Analysis (2014–2023) Article Snippet: A previous analysis based on the Article Title: Cardiovascular Safety Profile of BRAF and MEK Inhibitors in Melanoma: FAERS Data Through a Retrospective Disproportionality Analysis (2014-2023). Article Snippet: A previous analysis based on the Article Title: Comparative outcomes of adding SGLT2 inhibitors versus incretin-based therapies to insulin in type 2 diabetes. Article Snippet: Aims: To compare the risks of cardiovascular events and major microvascular complications associated with adding sodium-glucose cotransporter-2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP-4) inhibitors or glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to insulin therapy in patients with type 2 diabetes (T2D).. Methods: Using Taiwan’s National Health Insurance Research Database (2008–2021), we identified 20,655 propensity score–matched pairs of SGLT2 inhibitor and DPP-4 inhibitor users, and 10,445 matched pairs of SGLT2 inhibitor and GLP-1 RA users, all receiving concurrent insulin therapy.. Cox proportional hazards models were applied to assess outcome risks. Article Title: Formulae for calculating subgroup disease burden from overall and reported or assumed relative burden estimates Article Snippet: Second, the two observational studies used the same Article Title: Antihypertensive Medication Prescription Dispensation Among Pregnant Women in the United States: A Cohort Study Article Snippet: Design, Setting, and Participants: This retrospective cohort study used the Article Title: Evaluating the efficacy of blister packaging in improving medication adherence within psychiatry: A systematic literature review Article Snippet: A claims analysis of the Article Title: Respiratory syncytial virus-attributable hospitalizations among adults in high- and middle-income countries: application of the Global Burden of Disease framework Article Snippet: 15 , United States , United States MarketScan Databases (Truven) , 2000, 2010–2019 , Inpatient Claims , ICD-10 (Primary & secondary diagnoses). Magnetic Resonance Imaging:Article Title: Effects of an extended MRI approval of an implantable spinal cord stimulation device on compliance with manufacturer's recommendations. Article Snippet: Spinal cord stimulation (SCS) is an established and valuable invasive method for treating chronic neuropathic or ischemic pain of various origins.. Available data indicate that these patients with SCS implantation have a high need for magnetic resonance imaging (MRI) examinations: In an analysis of the Truven Health MarketScan Research Database, a commercial US database by Desai et al. 82% to 84% of SCSimplanted patients were expected to need at least one MRI scan within 5 years of implant.. Similarly, Farber et al. analyzed the same database for patients with failed back surgery syndrome and observed that patients with an SCS system had a greater need for imaging (rate ratio: 1.19); otherwise, they received fewer MRI scans compared with the general population (rate ratio: 0.50). |